This site uses cookies to store information on your computer. Learn more x

Q1 2018 Results

On Tuesday 8 May 2018 DSM published its Q1 2018 Results.

Commenting on the results, Feike Sijbesma, DSM's CEO and Chairman of the Managing Board said “We are very pleased that the strong underlying performance of our business continues, with growth well above market. In addition, we are currently benefitting from substantially higher prices in some vitamins due to exceptional supply disruptions in the industry, which are expected to be temporary and heavily weighted towards the first half of the year. These two combined resulted in a significantly higher outlook for the full year 2018, which we announced with our preliminary Q1 2018 results on 12 April 2018.”

Share price and volume

Share price> € 0.0 0.0%

More share info >